Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Zia U Rahman"'
Publikováno v:
The Journal of Poultry Science, Vol 43, Iss 3, Pp 286-295 (2006)
The influence of a non-feed removal molting program on certain parameters of cell mediated and humoral immune response of the laying birds during 2nd and 3rd production cycles were recorded. Birds at the end of their 1st production cycle were induced
Externí odkaz:
https://doaj.org/article/881aa42685fd492a82ca87815259ed45
Autor:
Jennifer Treece, Billy Brooks, Christine Moore, Lindsey C Shipley, Michael Zhang, Chidinma Onweni, Manar Jbara, Venugopal B Bhattad, Zia U Rahman, Kamesh Sivagnanam, Vijay Ramu, Timir K Paul
Publikováno v:
Circulation: Cardiovascular Quality and Outcomes. 11
Objective: Identify factors associated with readmissions following myocardial infarction. Background: The Hospital Readmission Reduction Program, implemented in 2012 under the Affordable Care Act, penalizes hospitals with higher rates of readmission,
Publikováno v:
Breast disease. 14
All research is subject to bias that may systematically distort results. Though over 50 types of bias in analytical research have been identified and many classification schemes proposed, this review focuses on the special problem of selection bias i
Autor:
Sharon H, Giordano, Daniel J, Booser, James L, Murray, Nuhad K, Ibrahim, Zia U, Rahman, Vicente, Valero, Richard L, Theriault, Marguerite F, Rosales, Edgardo, Rivera, Debbie, Frye, Michael, Ewer, Nelson G, Ordonez, Aman U, Buzdar, Gabriel N, Hortobagyi
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 8(11)
This Phase II study was designed to determine the efficacy and toxicity of combination doxorubicin and paclitaxel as front-line treatment for metastatic breast cancer.Eligible patients had no prior anthracycline or taxane therapy and normal cardiac f
Autor:
Ariela Noy, Martha Glenn, Ravi Verma, James R. Keenan, Daniel A. Filippa, Peter Maslak, Mark Weiss, Zia U. Rahman, Andrew D. Zelenetz
Publikováno v:
Blood. 97(7)
Patient–tumor-specific oligonucleotides were generated for the detection of minimal residual disease (MRD) in a highly specific and sensitive clonotypic polymerase chain reaction (cPCR). The clone-specific region of highest diversity, CDR-III, was